GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adocia (XPAR:ADOC) » Definitions » Cyclically Adjusted Price-to-FCF

Adocia (XPAR:ADOC) Cyclically Adjusted Price-to-FCF : (As of Jun. 01, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Adocia Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Adocia Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Adocia's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adocia Cyclically Adjusted Price-to-FCF Chart

Adocia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Adocia Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Adocia's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Adocia's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adocia's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adocia's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Adocia's Cyclically Adjusted Price-to-FCF falls into.



Adocia Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Adocia's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Adocia's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.461/118.3900*118.3900
=-0.461

Current CPI (Dec23) = 118.3900.

Adocia Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 4.854 99.860 5.755
201512 -1.075 100.040 -1.272
201612 -3.099 100.650 -3.645
201712 -3.527 101.850 -4.100
201812 0.726 103.470 0.831
201912 -1.682 104.980 -1.897
202012 -3.163 104.960 -3.568
202112 -2.776 107.850 -3.047
202212 -1.886 114.160 -1.956
202312 -0.461 118.390 -0.461

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Adocia  (XPAR:ADOC) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Adocia Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Adocia's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Adocia (XPAR:ADOC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adocia (XPAR:ADOC) » Definitions » Cyclically Adjusted Price-to-FCF
Traded in Other Exchanges
Address
115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.

Adocia (XPAR:ADOC) Headlines

From GuruFocus